Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 46: 252-257, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Craciun, A. M.
Right arrow Articles by Knapen, M. H.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Craciun, A. M.
Right arrow Articles by Knapen, M. H.J.
Related Collections
Right arrow Endocrinology and Metabolism
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2000;46:252-257.)
© 2000 American Association for Clinical Chemistry, Inc.

Articles

Evaluation of a Bead-based Enzyme Immunoassay for the Rapid Detection of Osteocalcin in Human Serum

Alexandra M. Craciun1, Cees Vermeer1, Hans-Georg Eisenwiener2, Norbert Drees2 and Marjo H.J. Knapen1,a

1 Department of Biochemistry and Cardiovascular Research Institute, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.

2 Hoffmann-La Roche Diagnostics, Basel 4070, Switzerland.
a Address corresponding to this author at: Department of Biochemistry, University of Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands. Fax 31-43-367-0992; e-mail m.knapen{at}bioch.unimaas.nl

Background: Circulating osteocalcin is a well-known marker for bone formation, but none of the commercial kits currently available can be used in automated systems. Here we present the first semiautomated assay for human serum osteocalcin.

Methods: Polystyrene beads were coated with antibodies against the COOH terminus of osteocalcin and used in the COBAS® EIA System. Osteocalcin was detected with peroxidase-conjugated antibodies against the osteocalcin NH2 terminus.

Results: The time required to analyze an unknown sample was 60 min, with a lower detection limit of 4.5 µg/L and a linear dose–response curve between 4.5 and 100 µg/L. The intraassay imprecision (CV) was 5–8% (n = 21); the interassay variation was 6–9% (n = 14). In samples from human volunteers and patients, data generated with the newly developed assay were comparable to those obtained with standard microtiter plate-based assays.

Conclusions: The coated beads assay may be implemented on fully automated analyzers, which not only may further reduce imprecision but may also substantially increase the applicability of osteocalcin as a marker for bone metabolism in the routine clinical setting.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.